Valuation : Camurus AB

Market Cap 34.46B 3.59B 3.09B 2.91B 2.65B 4.96B 340B 4.98B 13.32B 174B 13.49B 13.2B 554B P/E 2026 *
36x
P/E 2027 * 23.3x
Enterprise Value 29.94B 3.12B 2.68B 2.53B 2.3B 4.31B 295B 4.32B 11.57B 151B 11.72B 11.47B 482B EV / Sales 2026 *
10.5x
EV / Sales 2027 * 7.64x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.36%
1 week-0.77%
Current month-0.77%
1 month-4.61%
3 months+5.75%
6 months+20.42%
Current year-6.01%
1 week 577
Extreme 577
608.5
1 month 571.5
Extreme 571.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 282
Extreme 282
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
7/8/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/2/26 Sell

Chief Executive Officer

55,550 0.0928%
27/2/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-0.77%-20.08%+95.08% 3.59B
-0.88%-0.64%+58.05%+100.51% 1,024B
-1.15%+3.53%+54.25%+71.99% 663B
-1.44%+0.02%+20.65%+72.22% 453B
-0.95%+0.23%+28.96%+37.78% 349B
-3.18%+1.78%+20.66%+41.55% 295B
+0.30%+0.60%-0.40%+11.25% 253B
-1.55%+1.71%+54.15%+71.87% 236B
+0.02%+2.24%-14.59%-55.80% 206B
-0.15%+3.18%+31.24%+104.21% 187B
Average -1.03%+0.98%+23.29%+55.07% 367.09B
Weighted average by Cap. -1.06%+0.52%+37.18%+64.59%

Financials

2026 *2027 *
Net sales 2.86B 298M 256M 241M 220M 411M 28.17B 413M 1.1B 14.43B 1.12B 1.09B 45.95B 3.75B 391M 336M 316M 289M 540M 36.96B 541M 1.45B 18.93B 1.47B 1.44B 60.29B
Net income 949M 98.96M 85.1M 80.04M 73.07M 137M 9.36B 137M 367M 4.79B 372M 364M 15.27B 1.45B 151M 130M 122M 112M 209M 14.32B 210M 561M 7.33B 569M 556M 23.36B
Net Debt -4.52B -471M -405M -381M -348M -650M -44.54B -653M -1.75B -22.81B -1.77B -1.73B -72.66B -5.81B -606M -521M -490M -447M -836M -57.27B -839M -2.24B -29.33B -2.27B -2.22B -93.41B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
07/09/26 SEK 579.00 -1.36% 45,422
04/09/26 SEK 587.00 -2.17% 40,835
03/09/26 SEK 600.00 +1.01% 51,590
02/09/26 SEK 594.00 +0.59% 66,895
01/09/26 SEK 590.50 +1.20% 71,430
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
579.00SEK
Average target price
793.00SEK
Spread / Average Target
+36.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!